Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2551 USD | -7.20% | -4.60% | +68.49% |
05-14 | Earnings Flash (JAGX) JAGUAR HEALTH Reports Q1 Revenue $2.4M, vs. Street Est of $3M | MT |
05-14 | Transcript : Jaguar Health, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.49% | 75.93M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- JAGX Stock
- News Jaguar Health, Inc.
- Jaguar Health Says FDA Activates Third-Party Investigational New Drug Application for Crofelemer